Tag Archives: antidepressants

Plot twists in Soderbergh’s new movie Side Effects strain belief

Share I went to see Steven Soderbergh’s new film, Side Effects, with anticipation and dread. The movie, after all, carries the same name as my 2008 book, Side Effects and from what I could tell of the trailers, its plot … Continue reading

Posted in antidepressants, drug marketing, FDA, pharmaceutical industry, prescription drug abuse, university industry collaboration | Tagged , , , , , , , , | 2 Comments

Calls for action against authors of controversial Paxil study are getting louder

Share In the wake of GlaxoSmithKline’s record-breaking $3 billion settlement with the U.S. Department of Justice, a number of psychiatrists and researchers have redoubled their efforts to get Paxil study 329 retracted. As mentioned here and in other news accounts, the … Continue reading

Posted in antidepressants, clinical trials, conflicts of interest, drug marketing, ghostwriting, National Institutes of Health, pharmaceutical industry, scientific journal retractions, scientific misconduct, university industry collaboration | Tagged , , , , , , , | 2 Comments

Is the FDA violating its own mandate to approve safe drugs?

Share Is the Food and Drug Administration violating its own mandate to approve safe drugs? That was the question that Donald Light, co-author of The Risk for Prescription Drugs and a long-time medical sociologist, posed at a talk yesterday at … Continue reading

Posted in antidepressants, biotech industry, clinical trials, continuing medical education, drug marketing, FDA, health care costs, medical devices, patient care, pharmaceutical industry, scientific misconduct, suicide rates, Uncategorized | Tagged , , , , , , , , , | 2 Comments

Why 60 Minutes suddenly discovered the placebo effect in treating depression

Share When Dr. Irving Kirsch published his meta-analysis in PLoS Medicine in February 2008 showing that antidepressants were no more effective than a placebo in treating mild or moderate depression, the national news media ignored his explosive findings, for the … Continue reading

Posted in antidepressants, conflicts of interest, drug marketing, health care costs, pharmaceutical industry | Tagged , , , , | 16 Comments

Deceptive drug research practices explain why over-medicating of children still going on

Share A new report from the U.S. Government Accountability office confirms something that Rose Firestein, the eponymous prosecutor in the title of Side Effects: A Prosecutor, a Whistleblower and Bestselling Antidepressant on Trial noticed way back in the ’90s: that … Continue reading

Posted in antidepressants, antipsychotic drugs, clinical trials, conflicts of interest, drug marketing, FDA, ghostwriting, pharmaceutical industry | Tagged , , , , , , | 3 Comments

Drug and medical device industry launches push to weaken FDA oversight

Share With the Obama administration hobbled by a Republican-led Congress, the pharmaceutical and medical device industry seems to have launched a concerted push to roll back regulatory initiatives designed to protect consumers from unproven or unsafe drugs and medical devices. … Continue reading

Posted in antidepressants, conflicts of interest, FDA, medical devices, suicide rates | Tagged , , , , , | 2 Comments